Athersys Stock News

It can be tough to find public anti-aging companies to invest in.

The

NuCana (NASDAQ:NCNA) and Athersys (NASDAQ:ATHX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends,

The stem cell stock jumped after a major Wall Street firm initiated coverage, but there's a catch.

Upgrades * Credit Suisse changed the rating for Allstate Corp (NYSE: ALL) from Underperform to Neutral. Allstate earned $3.54 in the first quarter, compared to $2.30 in the year-ago quarter. The sto

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Ev

According to a new market research report “COVID-19 Diagnostics (PCR Testing, Antibody Testing) and Therapy (Immunotherapy, Vaccines, Antiviral, Cell-based,

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80%

University of California, San Diego researchers edited a gene called CISH from the immune system's natural killer (NK) cells, freeing up the signaling of cytokines—molecules that direct immune cells

Q1 2020 Athersys Inc Earnings Call

The stem cell stock recovered from a lousy April as the company fed investors updates for its COVID-19 programs.

Jun 08, 2020 (Market Insight Reports) -- Selbyville, Delaware According to Market Study Report, Provides A Detailed Overview Of Regenerative Medicine Market...

The

In just a few months, leronlimab in treatment of COVID-19 has gone from a curiosity to driving the bus. With urging from the FDA, CytoDyn is closing its hugely

SAN FRANCISCO, May 25, 2020 /PRNewswire via COMTEX/ -- SAN FRANCISCO, May 25, 2020 /PRNewswire/ -- The global tissue engineering market size is expected to...